JPS5594319A - Drug for external use consisting of liver oil of swellfish - Google Patents

Drug for external use consisting of liver oil of swellfish

Info

Publication number
JPS5594319A
JPS5594319A JP182279A JP182279A JPS5594319A JP S5594319 A JPS5594319 A JP S5594319A JP 182279 A JP182279 A JP 182279A JP 182279 A JP182279 A JP 182279A JP S5594319 A JPS5594319 A JP S5594319A
Authority
JP
Japan
Prior art keywords
swellfish
drug
liver oil
external use
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP182279A
Other languages
Japanese (ja)
Inventor
Yoshio Otaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP182279A priority Critical patent/JPS5594319A/en
Publication of JPS5594319A publication Critical patent/JPS5594319A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: A drug for external use capable of allaying pain and protecting a wound from the open air, consisting of the liver oil of swellfish having tetrodotoxin.
CONSTITUTION: A drug for external use available for curing a wound, obtained from the liver oil from liver in swellfish having tetrodotoxin. The liver oil of swellfish contains less than fatal dose (0.1W10γ per kg of swellfish) of tetrodotoxin. Since its small amount is capable of paralyzing a sensory nerve, it has a pain- killing action. Many kinds of higher fatty acids and higher unsaturated hydrocarbons contained in the liver cover the wound of a burn to prevent the air oxidation or bacterial infection.
COPYRIGHT: (C)1980,JPO&Japio
JP182279A 1979-01-09 1979-01-09 Drug for external use consisting of liver oil of swellfish Pending JPS5594319A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP182279A JPS5594319A (en) 1979-01-09 1979-01-09 Drug for external use consisting of liver oil of swellfish

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP182279A JPS5594319A (en) 1979-01-09 1979-01-09 Drug for external use consisting of liver oil of swellfish

Publications (1)

Publication Number Publication Date
JPS5594319A true JPS5594319A (en) 1980-07-17

Family

ID=11512246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP182279A Pending JPS5594319A (en) 1979-01-09 1979-01-09 Drug for external use consisting of liver oil of swellfish

Country Status (1)

Country Link
JP (1) JPS5594319A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03153627A (en) * 1989-11-11 1991-07-01 ▲ゆ▼　耀庭 Medicament containing swellfish poison as pharmaceutically effective component, its preparation and extraction of said swellfish poison
WO1998043619A3 (en) * 1997-04-02 1998-12-30 Univ California Method of local anesthesia
EP0750909A4 (en) * 1994-03-17 2000-07-26 Nanning Maple Leaf Pharmaceuti The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
EP1128844A4 (en) * 1998-10-27 2002-06-12 Mayo Foundation Methods for enhancing wound healing
KR100409133B1 (en) * 2001-02-03 2003-12-06 임갑만 hemorrhoids treatment material using for swellfish spawn and its thereby manufacturing method
EP1405639A4 (en) * 2001-06-22 2004-08-04 Wex Medical Ltd Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals
JP2006214742A (en) * 2005-02-01 2006-08-17 Nagasaki Prefecture Toxicity examination method of livers of plurality of puffer fishes, and puffer fish liver processed product using the method
WO2006129381A1 (en) * 2005-05-30 2006-12-07 Manbou Corp. Skin cell activator extracted from liver of fish or shellfish and hair growth agent using the same

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03153627A (en) * 1989-11-11 1991-07-01 ▲ゆ▼　耀庭 Medicament containing swellfish poison as pharmaceutically effective component, its preparation and extraction of said swellfish poison
EP0750909A4 (en) * 1994-03-17 2000-07-26 Nanning Maple Leaf Pharmaceuti The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
WO1998043619A3 (en) * 1997-04-02 1998-12-30 Univ California Method of local anesthesia
EP1128844A4 (en) * 1998-10-27 2002-06-12 Mayo Foundation Methods for enhancing wound healing
US6447787B1 (en) 1998-10-27 2002-09-10 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
KR100409133B1 (en) * 2001-02-03 2003-12-06 임갑만 hemorrhoids treatment material using for swellfish spawn and its thereby manufacturing method
EP1405639A4 (en) * 2001-06-22 2004-08-04 Wex Medical Ltd Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals
JP2006214742A (en) * 2005-02-01 2006-08-17 Nagasaki Prefecture Toxicity examination method of livers of plurality of puffer fishes, and puffer fish liver processed product using the method
JP4690062B2 (en) * 2005-02-01 2011-06-01 長崎県 Multiple puffer liver toxicity test methods and processed puffer liver products using this toxicity test method
WO2006129381A1 (en) * 2005-05-30 2006-12-07 Manbou Corp. Skin cell activator extracted from liver of fish or shellfish and hair growth agent using the same

Similar Documents

Publication Publication Date Title
GB2091100B (en) Oily composition for the treatment of keratin substances and the skin
WO1994027589A3 (en) Antidepressant dosage form
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
ATE369118T1 (en) NEW MEDICINAL FORMULATION CONTAINING BUDESONIDE
FR2430410B1 (en) PHENETHANOLAMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE9103742U1 (en)
JPS5594319A (en) Drug for external use consisting of liver oil of swellfish
JPS55133376A (en) 55substituted pyranone compound and its use as medicine
NZ190769A (en) Oil-in-water insecticidal and acaricidal emulsion
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
JPS54145670A (en) Thiazolidinone compound*its manufacture and noxious living thing killing composition containing said compound as active component
EP0023704A3 (en) Novel method of administering propranolol and novel dosage forms containing same
JPS54128544A (en) Substituted nnphenylln**fluorobenzoylurea* its manufacture and noxious livin expellant containing it as active component
DE69314463T2 (en) SKIN REGENERATING COSMETIC COMPOSITION
JPS54145688A (en) Organic compound*its manufacture and medical composition containing it as active component
MY8400315A (en) Preparation of stabilised maneb and fungicidal compositions comprising the same
JPS554383A (en) Toilet composition for oily skin and hair treatment*its active compound and its manufacture
JPS55133375A (en) 66substituted pyranone compound and its use as medicine
JPS55136296A (en) Phosphorylhydrazine and insecticidal composition as active component of phosphorylhydrazine
JPS52125139A (en) Fluoroacylresorcinncontaining pharmaceutical*cosmetic and agent for killing harmful organisms
JPS5620588A (en) 66alkyll77phenyll1*66naphthylidinee5*6h**one derivative* its manufacture and drug as active component thereof
DE69300037T2 (en) Use of bucillamine in the manufacture of a medicament for the treatment of cystinuria.
ATE69949T1 (en) LIPOSOMES WITH INHALATION ALLERGENS FOR THE TREATMENT OF ALLERGIES, METHOD FOR THEIR MANUFACTURE AND MEDICATIONS CONTAINING THEM.
ZW17581A1 (en) N-(1-allyl-2-pyrrolidinyl-methoxy 4-amino 5-methysulfamoyl benzamide its method of preparation and its use as a medicament
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety